Suppr超能文献

血清丙氨酸氨基转移酶上正常范围上限值可用于识别慢性肝病风险人群。

Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease.

机构信息

Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

出版信息

Liver Int. 2012 Jul;32(6):937-44. doi: 10.1111/j.1478-3231.2011.02749.x. Epub 2012 Jan 20.

Abstract

BACKGROUND/AIMS: Serum alanine aminotransferase (ALT) is an easily available, low-cost screening tool for detecting silent chronic liver disease. Recent studies have suggested that the currently accepted healthy ALT thresholds be lowered.

METHODS

In this retrospective cross-sectional study, we determined upper thresholds for ALT values in a nationally representative healthy cohort (n = 3337) from the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). Sensitivity and specificity of the currently used ALT threshold (40 IU/L, regardless of gender) was compared against study-derived, gender-specific ALT thresholds for detecting individuals at risk for chronic liver disease in 27 913 health check-up participants.

RESULTS

The 95th percentile levels for ALT in healthy weight, metabolically normal, liver disease-free KNHANES participants were 34 IU/L for men and 25 IU/L for women. The prevalence of ALT elevation among health check-up participants was 11.0% in currently used thresholds, and increased to 22.6% with study-derived, gender-specific thresholds. Of the population who were additionally defined to have elevated ALT levels under new ALT threshold, 65.7% were at risk for chronic liver disease. Sensitivity for detecting individuals at risk for chronic liver disease improved from 18 to 33% with new thresholds whereas a trade-off in specificity (from 96 to 88%) was observed.

CONCLUSIONS

It is recommendable to lower the current ALT thresholds to better identify individuals at risk for chronic liver disease.

摘要

背景/目的:血清丙氨酸氨基转移酶(ALT)是一种易于获得且成本低廉的筛查工具,可用于检测无症状慢性肝病。最近的研究表明,目前接受的健康 ALT 阈值应降低。

方法

在这项回顾性横断面研究中,我们在全国代表性健康队列(来自第四次韩国国家健康和营养检查调查(KNHANES IV)的 n = 3337 名)中确定了 ALT 值的上限阈值。与研究衍生的、性别特异性的 ALT 阈值相比,目前使用的 ALT 阈值(无论性别如何,均为 40 IU/L)检测患有慢性肝病风险的个体的敏感性和特异性在 27913 名健康检查参与者中进行了比较。

结果

在健康体重、代谢正常、无肝病的 KNHANES 参与者中,ALT 的第 95 百分位数水平为男性 34 IU/L,女性 25 IU/L。在目前使用的阈值下,健康检查参与者中 ALT 升高的患病率为 11.0%,而使用研究衍生的、性别特异性的阈值则升高至 22.6%。在新 ALT 阈值下,另外定义为 ALT 水平升高的人群中,有 65.7%存在慢性肝病风险。使用新阈值检测慢性肝病风险个体的敏感性从 18%提高到 33%,但特异性(从 96%降至 88%)存在折衷。

结论

建议降低目前的 ALT 阈值,以更好地识别慢性肝病风险个体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验